Cramer’s Stop Trading: Moderna

(2:26)

Moderna asks investors to wait for full data on flu vaccine amid selloff

(1:13)

Moderna raises eyebrows with stock offering ahead of STAT News report

(9:1econd)

Moderna CEO: ‘We are seeing very strong’ vaccine demand

(7:37)

Moderna CEO on kick off of phase three Covid-19 vaccine trial

(4:20)

Moderna shares drop after company cuts Covid-19 vaccine outlook

(2:31)

Moderna stock rises after analyst upgrade, price target raise

(2:11)

Moderna beats estimates and releases positive vaccine data

(2:11)

Moderna stock up after upgrade to Buy from Neutral

(38)

Moderna CEO on importance of FDA approval: It's 'the credibility of our vaccine'

(10:58)

Moderna CEO talks huge earnings beat, COVID-19 vaccine sales, new boosters

(8:17)

Pfizer CEO Albert Bourla: Our 2025 focus is on pipeline

(5:51)

Moderna CEO Stéphane Bancel Is Interviewed by SandboxAQ CEOJack Hidary at #FII8

(15:37)

CEO Chat with Stéphane Bancel @ Flagship Studio

(15:40)

What if mRNA could be a drug? | Stephane Bancel | TEDxBeaconStreet

(14:12)

Moderna, Merck Skin Cancer Vaccine Cuts Risks of Death in Trial

(9:41)

Moderna stock trading on Covid expectations, Oppenheimer managing director says

(3:4)

Moderna is a 'trade' on Bird Flu vaccine pop, says Mizuho's Jared Holz

(3:3)

Moderna CEO on using mRNA, Amazon cloud to develop a new class of medicine

(7:59)

Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold

(7:)

Moderna CEO's vaccine warning rattles markets

(1:28)

Moderna misses in Q3, cuts forecast for COVID vaccine revenue

(1:5)

Melanoma vaccine data should make investors more positive on Moderna, says Jefferies' Michael Yee

(3:19)

How Moderna became the frontrunner for coronavirus vaccine

(3:30)

Moderna forecasts $17-22 billion in sales for 2022

(1:42)

Moderna stock hits all time high

(3:33)

Moderna CEO Stephane Bancel on executive stock sales

(5:13)

Moderna plans stock buyback, sales forecast unchanged

(1:29)

Moderna CEO on its 94.5% effective Covid-19 vaccine: We hope to get it to market soon

(4:40)

Moderna chief scientist on promising new vaccine data

(4:16)